S.C. Helios Valuation

Is HEAL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of HEAL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate HEAL's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate HEAL's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for HEAL?

Key metric: As HEAL is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for HEAL. This is calculated by dividing HEAL's market cap by their current earnings.
What is HEAL's PE Ratio?
PE Ratio	9x
Earnings	RON 3.79m
Market Cap	RON 34.16m

HEAL key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.1x
Enterprise Value/EBITDA	5.2x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does HEAL's PE Ratio compare to its peers?

The above table shows the PE ratio for HEAL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	36.4x
MINO S.C. Mindo	48.1x	n/a	RON 31.4m
MACO S.C. Macofil	5.3x	n/a	RON 70.1m
PREB S.C. Prebet Aiud	87.7x	n/a	RON 87.8m
INSI S.C. Industria Sarmei Campia Turzii	4.6x	n/a	RON 58.9m
HEAL S.C. Helios	9x	n/a	RON 34.2m

Price-To-Earnings vs Peers: HEAL is good value based on its Price-To-Earnings Ratio (9x) compared to the peer average (36.4x).

Price to Earnings Ratio vs Industry

How does HEAL's PE Ratio compare vs other companies in the European Basic Materials Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: HEAL is good value based on its Price-To-Earnings Ratio (9x) compared to the European Basic Materials industry average (12.8x).

Price to Earnings Ratio vs Fair Ratio

What is HEAL's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

HEAL PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	9x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate HEAL's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.